TZDs inhibit the Cdk5-mediated Ser273 phosphorylation of PPARγ in adipose tissue (52), which in turn, down-regulate expression of genes involved in obesity, including adipsin, a fat-cell-selective gene, and adiponectin, an insulin-sensitizing adipokine (53). This evidence concerns the gene ADIPOQ and obesity disorder.